left-caret
Anwaelte
Image: Chaobo Fan

Chaobo Fan

Partner, Corporate Department
Hong Kong
21-22/F Bank of China Tower
1 Garden Road
Central Hong Kong SAR, China

Fax: (852) 3192 9721

Overview

Chaobo Fan is a partner in the Corporate practice of Paul Hastings and is based in the Hong Kong office.

Mr. Fan's practice focuses on securities offerings, mergers and acquisitions, and other general corporate matters. Mr. Fan is fluent in Mandarin and English.

Accolades and Recognitions

Admitted as a Hong Kong solicitor and to the New York State Bar

Education

  • LLM, New York University School of Law, 2010

  • LLB, China Univ. of Political Science and Law, 2009

Recent Representations

Capital Markets

  • Morgan Stanley, CICC and Credit Suisse as the joint sponsors on the US$281 million global offering and initial public offering of SciClone Pharmaceuticals, a leading biopharmaceutical company based in China , on the Main Board of the Hong Kong Stock Exchange.

  • CCB International as the sole sponsor, sole global coordinator and joint bookrunner, and CMB International, BOCOM International,Haitong International, Guotai Junan Securities, CRIC Securities, Yue Xiu Securities, Sheng Yuan Securities, ABCI Capital and CMBC Securities as other joint bookrunners, on the US$182 million global offering and initial public offering of Leading Holdings Group Limited, a leading Chinese property developer, on the Main Board of the Hong Kong Stock Exchange.

  • ABCI Capital, CLSA and Haitong International as the joint sponsors on the US$331 million global offering and IPO of Radiance Holdings, a leading Chinese property developer, on the Main Board of the Hong Kong Stock Exchange.  

  • Weihai City Commercial Bank Co., Ltd., one of the largest city commercial bank in Shandong Province in China, on its US$365 million global offering and listing of its H Shares on the Main Board of the Hong Kong Stock Exchange. Huatai Financial Holdings, CICC and CMB International acted as the joint sponsors for the listing.

  • China Bohai Bank, a nationwide joint-stock commercial bank in China, on its US$1.77 billion global offering and listing of its H Shares on the Main Board of the Hong Kong Stock Exchange. CCB International, Haitong International, ABCI Capital and CLSA acted as the joint sponsors.

  • Redsun Services Group Limited, a leading property management company based in Jiangsu Province, China, on its US$53.5 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange. ABCI Capital acted as the sole sponsor and joint global coordinators with CCB International, CMB International and ICBC International for the listing.

  • Represented the underwriters on the US$1.16 billion initial public offering of Shenwan Hongyuan Group Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented the underwriters on the US$129 million initial public offering of 51 Credit Card Inc. and its listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented the underwriters on the spin-off of A-Living Services Co., Ltd. from Agile Group Holdings Limited and its US$524 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented the underwriters on the US$868 million initial public offering of Yixin Group Limited and its listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented the underwriters on the US$1.38 billion initial public offering of China Merchants Securities Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented the underwriters on the US$108 million initial public offering of Golden Throat Holdings Group Company Limited and its listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented the underwriters on the US$1.34 billion initial public offering of Shengjing Bank Co., Ltd. and its listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented Universal Health International Group Holding Limited on its US$188 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange.*

  • Represented Shanghai Pharmaceuticals Holding Co., Ltd. on its US$400 million placing of H shares.*

M&A

  • Represented COSCO Shipping Development Co., Ltd. on its very substantial acquisition and major disposal of various businesses and assets as part of the material asset restructurings between COSCO and China Shipping.*

  • Represented Elife Holdings on its acquisition of a smart terminal business.*

Compliance Matters

  • Represented a number of listed companies, including Everbright Securities Co., Ltd., GF Securities Co., Ltd., Shanghai Pharmaceuticals Holding Co., Ltd., and Shengjing Bank Co., Ltd. in relation to their compliance matters under the Hong Kong Listing Rules and other relevant laws and regulations.*

*Matter handled prior to joining the firm

Languages

englisch

Admissions

Hong Kong Solicitor
New York Bar

Education

New York University School of Law, LL.M. 2010
China University of Political Science and Law (Zhongguo Zhengfa Daxue), LL.B. 2009

Nehmen Sie Kontakt mit uns auf

Kontaktieren Sie uns